Telomere length in human liver diseases

Area of Science:

• Genetics and Genomics
• Hepatology and Gastroenterology
• Oncology

Background:

• Telomeres, protective caps on chromosome ends, are crucial for maintaining genomic stability.
• Chronic liver diseases and hepatocellular carcinoma (HCC) are associated with genomic instability.
• The role of telomere length and its regulation in hepatocarcinogenesis remains incompletely understood.

Purpose of the Study:

• To investigate the relationship between telomere length and the progression of liver disease, from chronic hepatitis to HCC.
• To assess telomere restriction fragment (TRF) length in normal liver, chronic hepatitis, liver cirrhosis, and HCC tissues.
• To explore the correlation between telomere length, HCC differentiation, and tumor size.

Main Methods:

• Measurement of mean telomere restriction fragment (TRF) length in human liver tissue samples.
• Analysis included normal liver (n=13), chronic hepatitis (n=11), liver cirrhosis (n=24), and HCC (n=24).
• Comparison of TRF length ratios between HCC and surrounding liver tissue, stratified by differentiation and size.

Main Results:

• Mean TRF length significantly decreased with disease progression: normal (7.8 kb) > chronic hepatitis (7.1 kb) > cirrhosis (6.4 kb) > HCC (5.2 kb).
• HCC telomere length was significantly shorter than in other chronic liver diseases (p < 0.05).
• Poorly differentiated HCC showed a higher telomere length ratio to surrounding liver than moderately differentiated HCC. Moderately differentiated HCC showed a size-dependent telomere ratio, increasing over 50 mm.

Conclusions:

• Telomere-mediated gene stability is reduced during the progression of chronic liver disease and hepatocarcinogenesis.
• Telomerase activation is suggested in poorly differentiated HCC and in moderately differentiated HCC exceeding 50 mm in diameter.
• These findings highlight the role of telomere dynamics in the development and progression of liver cancer.